ClinicalTrials.Veeva

Menu

Microcirculation of the Thenar Eminence

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Elective Cardiac Surgery

Treatments

Other: microcirculatory reactivity

Study type

Observational

Funder types

Other

Identifiers

NCT01748266
1008018
2010-A00172-37 (Other Identifier)

Details and patient eligibility

About

Microcirculatory disturbances following cardiac surgery with cardiopulmonary bypass (CPB) have been thought to be at the origin of organ dysfunction. Though, few studies correlated microvascular alterations with outcome. Investigators aimed at firstly describing microcirculation with near infra red spectroscopy (NIRS) and secondly correlating NIRS parameters with intensive care length of stay and organ dysfunction.

Full description

40 patients at high risk of post operative systemic inflammatory response syndrome after an elective cardiac surgery with CPB were included in this prospective observational study. Patients were studied during the first 48 postoperative hours. Microcirculation of the thenar eminence was analyzed by NIRS technology, through the StO2 and the resaturation slope after an ischemic challenge. Organ dysfunction was assessed with the SOFA score.

Enrollment

40 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • scheduled for an elective cardiac surgery at high risk of post operative systemic inflammatory response syndrome

Exclusion criteria

  • BMI>35

Trial design

40 participants in 1 patient group

microcirculatory reactivity
Description:
Patients were studied during the first 48 postoperative hours. Microcirculation of the thenar eminence was analyzed by NIRS technology, through the StO2 and the resaturation slope after an ischemic challenge.
Treatment:
Other: microcirculatory reactivity

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems